 |
Recombinant human superoxide dismutase |
|---|---|
| Trade Name | Oxsodrol |
| Orphan Indication | Bronchopulmonary dysplasia |
| USA Market Approval | USA |
| USA Designation Date | 1991-04-18 00:00:00 |
| Sponsor | Savient Pharmaceuticals, Inc.;One Tower Center Boulevard, 12th floor;East Brunswick, New Jersey, 08816 |
